Skip to main content

Stereotaxis, Inc.

STXS
Exchange
NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001289340

No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Stereotaxis, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of STXS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders8571−14
Shares36.6M36.1M−485.1K (−1.3%)
Value$67.3M$65.1M−$2.28M (−3.4%)

New holders (4)

Institutions that held Stereotaxis, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to STXS in Q3 2022
InstitutionSharesValue% of portfolio
AlphaCentric Advisors LLC500,000$900.0K0.92%
Bridgeway Capital Management, LLC76,200$137.0K0.00%
Robertson Stephens Wealth Management, LLC25,000$45.0K0.01%
Warberg Asset Management LLC10,000$18.0K0.00%

Sold out (18)

Institutions that held Stereotaxis, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.